Month: <span>September 2024</span>

Home / 2024 / September
METTL family: A key regulator of cellular function in health and disease
Post

METTL family: A key regulator of cellular function in health and disease

August 20, 2024 by Sichuan International Medical Exchange and Promotion Association Modifications Involved in The Process of Gene Expression: From Transcription to Protein Activation and Depolymerization. Numerous processes are involved in gene expression. Histone modifications facilitate DNA transcription. DNA, in turn, undergoes modifications within proteins. mRNA modification is employed for nuclear and cytoplasmic localization. Once...

Therapeutic app might ease anxiety in young adults
Post

Therapeutic app might ease anxiety in young adults

August 21, 2024 by Ernie Mundell It’s not a replacement for actual psychotherapy, but a newly designed app could help young adults with mental health issues lower their anxiety, researchers report. The app, dubbed Maya, “can be an accessible and impactful tool for those looking for support around anxiety. It is incredible to see our...

Cognitive behavioral therapy found to have clear benefits for cancer survivors
Post

Cognitive behavioral therapy found to have clear benefits for cancer survivors

August 21, 2024 by Wiley Credit: Pixabay/CC0 Public DomainA recent analysis of all relevant published studies reveals clear benefits of cognitive behavioral therapy (CBT) for improving mental health and quality of life in cancer survivors. The findings, which are published in Cancer Medicine, extend CBT’s effects beyond what has long been known in the general...

Post

Inhaler misuse leads to mismanagement of COPD symptoms, increased exacerbations

News Release 20-Aug-2024 Patients need additional education on proper inhaler use to improve outcomes Peer-Reviewed PublicationCOPD Foundation MIAMI (August 20, 2024) – Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper inhaler use is needed to improve health outcomes,...

The FDA calls them ‘recalls,’ yet the targeted medical devices often remain in use
Post

The FDA calls them ‘recalls,’ yet the targeted medical devices often remain in use

August 20, 2024 by David Hilzenrath, Kaiser Health News Credit: Unsplash/CC0 Public DomainIn 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device—”a Class I recall, the most serious type,” the FDA said. “Use of this device may cause serious injuries or death,” an FDA notice about the recall said. But neither...

U.S. births continue to fall, dropping by 17% since 2007
Post

U.S. births continue to fall, dropping by 17% since 2007

August 20, 2024 by Ernie Mundell Final government data finds the number of U.S. births falling by 2% last year compared to 2022, continuing a decades-long decline. Overall, annual U.S. birth numbers have fallen by 17% since peaking in 2007, according to the new report from the U.S. Centers for Disease Control and Prevention. The...

Post

Sugar Substitutes, Originally Meant to Reduce Health Risk, May Wreak Havoc on Gut Microbiomes

Medscape Diabetes & EndocrinologyCOMMENTARY Brandy W. Root, RDN DISCLOSURES | August 16, 2024 Commercial sugar substitutes have been used since the late 1800s when saccharin was accidentally developed by a chemist at Johns Hopkins University. Due to widespread sugar rationing during World Wars I and II, saccharin grew in popularity. In more recent times, the...

ESMO: Combination therapy reduced agitated delirium in patients with advanced cancers
Post

ESMO: Combination therapy reduced agitated delirium in patients with advanced cancers

September 15, 2024 by University of Texas M. D. Anderson Cancer Center Credit: Unsplash/CC0 Public DomainTreatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD...

Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds
Post

Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds

September 15, 2024 by Weill Cornell Medical College Credit: CC0 Public DomainLong-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators...

Post

MNT Investigates: Do ulcerative colitis treatments reduce the risk of heart attack?

Research has linked ulcerative colitis (UC) to an increased risk of heart disease, including heart attack and stroke. Some UC treatments may help reduce the risk of heart problems, though more research is necessary. UC refers to chronic inflammation in the inner lining of the large intestine. People with UC may also develop inflammation in...